Skip to main content
SciBX: Science-Business eXchange
As published Thursday, September 18, 2014

  • Cover Story: Neutralizing HIV rebound

    By Benjamin Boettner, Associate Editor

    Neutralizing HIV rebound

    Although antiretroviral therapies have transformed HIV infection into a chronically manageable disease, they have made little impact in reaching the latent viral reservoirs that are sources of disease rebound. Researchers at The Rockefeller University have found that broadly neutralizing antibodies against the HIV envelope protein, when given with viral inducers, can purge the reservoirs of virus and potentially eliminate the virus from its last bastion.1

    Full Article


  • This Week in Therapeutics

    Countering MEK and BRAF inhibitor resistance in cancer by disrupting eIF4F; treating DMD with CRISPR-mediated genomic editing; inhibiting CRFR1 signaling to prevent hypoxia-induced cerebral edema; and more...

  • more therapeutics news
  • This Week in Techniques

    A marmoset model of MERS-CoV infection; a fully functional thymus generated from reprogrammed fibroblasts; noninvasive methods for diagnosing Creutzfeldt-Jakob disease; and more...

  • more techniques news
Subscribe Now
Free Trial